🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anton P. Porsteinsson

University of Rochester Medicine

ORCID: 0000-0002-0166-1738

Also affiliated with Alzheimer’s Disease Neuroimaging Initiative

MedicineNeurosciencePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.178Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

International Psychogeriatrics(2023)10.1017/s1041610223000327
Top 66%
0.178DataRank
Top 66%2 citations

Clara Chen, Ethan Mah, Alex Kiss, Abby Li, Dave Shade +15 more

Papers

Driven by 12 papers — median percentile 34. Top paper: “Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease”.

Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease

Nature Communications(2021)10.1038/s41467-021-24220-7
N/A
1.1DataRank · unranked
36 citations

Tuğba Öztürk, Alexander Kollhoff, Whitney Wharton, J. Christina Howell, Alzheimer’s Disease Neuroimaging Initiative +95 more

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

Scientific Reports(2017)10.1038/srep44272
N/A
0.604DataRank · unranked
55 citations

Chanxiu Li, Lei Du, Xiaohui Yao, Jingwen Yan, Shannon L. Risacher +241 more

Effect of online tDCS to left somatomotor cortex on neuropsychiatric symptoms among older adults at risk for dementia

Cortex(2022)10.1016/j.cortex.2022.10.015
N/A
0.523DataRank · unranked
17 citations

Mia Anthony, Duje Tadin, Anton P. Porsteinsson, Kathi L. Heffner, Feng Lin +1 more

Targeting autonomic flexibility to enhance cognitive training outcomes in older adults with mild cognitive impairment: study protocol for a randomized controlled trial

Trials(2021)10.1186/s13063-021-05530-z
N/A
0.522DataRank · unranked
13 citations

Kathi L. Heffner, Richard Gevirtz, Zhengwu Zhang, Duje Tadin, Anton P. Porsteinsson +1 more

iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease

Molecular Psychiatry(2024)10.1038/s41380-024-02629-y
N/A
0.500DataRank · unranked
27 citations

Ram Sagar, Ariadni Xydia, Alejandro Lopez-Montes, Jacobo Mintzer, Paul B. Rosenberg +5 more

Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

International Psychogeriatrics(2023)10.1017/s1041610223000327
Top 66%
0.178DataRank
Top 66%2 citations

Clara Chen, Ethan Mah, Alex Kiss, Abby Li, Dave Shade +15 more

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00663-w
N/A
0DataRank · unranked
357 citations

Susan Abushakra, John A. Hey, Anton P. Porsteinsson, Marwan N. Sabbagh, Martin Tolar

APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics

Alzheimer s & Dementia Translational Research & Clinical Interventions(2024)10.1002/trc2.12498
N/A
0DataRank · unranked
22 citations

Anton P. Porsteinsson, Marwan Sabbagh, David Watson, Aidan Power, Earvin Liang +8 more

Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)

International Journal of Geriatric Psychiatry(2024)10.1002/gps.6108
N/A
0DataRank · unranked
4 citations

Jamie Perin, Alden L. Gross, David Shade, Krista L. Lanctôt, Alan J. Lerner +10 more

Correlation between changes in apathy and cognition in Alzheimer’s disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

International Psychogeriatrics(2024)10.1016/j.inpsyc.2024.100012
N/A
0DataRank · unranked
2 citations

Shankar Tumati, Jamie Perin, Luc Rivet, Danielle Soares Rocha Vieira, Paul B. Rosenberg +12 more

Cohen-mansfield agitation inventory total score as a measure of agitation and aggression in Alzheimer’s disease: A factor analysis

International Psychogeriatrics(2025)10.1016/j.inpsyc.2025.100056
N/A
0DataRank · unranked
3 citations

Mary Sano, Constantine G. Lyketsos, Paul B. Rosenberg, Anton P. Porsteinsson, Bruce L. Brown +3 more

Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial

American Journal of Geriatric Psychiatry(2023)10.1016/j.jagp.2023.06.002
N/A
0DataRank · unranked
5 citations

Luc Rivet, Shankar Tumati, Jamie Perin, Krushnaa Sankhe, Danielle Soares Rocha Vieira +13 more